A Prospective, Noninterventional Follow-Up Study of Children Aged 23 to 25 Months, Born to Mothers Who Received Hydroxyprogesterone Caproate Injection, 250 mg/mL, or Vehicle for Prevention of Preterm Birth
Clinical trial NCT01146990 · COMPLETED
Trial details
- NCT number
- NCT01146990
- Sponsor
- AMAG Pharmaceuticals, Inc.
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2010-11-09
- Primary completion
- 2020-08-13
- Enrollment
- 245
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.